Skip to content

Study · Animal study (in vivo) · rat · 1994

2 results

Vasoactive intestinal peptide stimulates ACTH and corticosterone release after injection into the PVN.

Alexander LD, Sander LD

Regulatory peptides1 May 1994Cited by 31 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In male rats, VIP injected into the paraventricular nucleus increased plasma ACTH in a dose-dependent manner, to 167% of time-matched controls at the highest dose.

    In plain wordsIn rats, VIP injected into a brain region raised blood ACTH, a stress hormone, in a dose-dependent way.

    Outcome
    IncreasePlasma ACTH
    Study

    ratn: not reported in source

    fasted, freely-moving male rats with a PVN cannula
    Comparator
    Saline
    Outcome group
    Stress hormones · Endocrine and hormones
    Studied dose
    0.15-3.0 nmol/rat · injection into the PVNAs given in this study (rat).

    Measurements

    Plasma ACTH
    167 % of time-matched controls
    highest VIP dose

    Source sentences

    Summary
    PVN administration of VIP increased the plasma ACTH and CORT levels in a dose-dependent manner and the maximal effect was obtained at 15 min after administration.
    2 context sentences
    Summary · context
    At the highest dose tested, VIP increased ACTH and CORT to 167% and 342% of time-matched controls
    Summary · context
    Male rats, chronically implanted with a hypothalamic paraventricular nucleus (PVN) cannula, were injected with VIP doses (0.15-3.0 nmol/rat) of VIP or saline (control).
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In male rats, VIP injected into the paraventricular nucleus increased plasma corticosterone in a dose-dependent manner, to 342% of time-matched controls at the highest dose.

    In plain wordsIn rats, VIP injected into a brain region raised blood corticosterone, a stress hormone, in a dose-dependent way.

    Outcome
    IncreasePlasma corticosterone
    Study

    ratn: not reported in source

    fasted, freely-moving male rats with a PVN cannula
    Comparator
    Saline
    Outcome group
    Stress hormones · Endocrine and hormones
    Studied dose
    0.15-3.0 nmol/rat · injection into the PVNAs given in this study (rat).

    Measurements

    Plasma corticosterone
    342 % of time-matched controls
    highest VIP dose

    Source sentences

    Summary
    PVN administration of VIP increased the plasma ACTH and CORT levels in a dose-dependent manner and the maximal effect was obtained at 15 min after administration.
    2 context sentences
    Summary · context
    At the highest dose tested, VIP increased ACTH and CORT to 167% and 342% of time-matched controls
    Summary · context
    Male rats, chronically implanted with a hypothalamic paraventricular nucleus (PVN) cannula, were injected with VIP doses (0.15-3.0 nmol/rat) of VIP or saline (control).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    27 Oct 2026, 16:35 UTC

    Study data updated · source update from Europe PMC

  2. Version 2

    12 Oct 2026, 12:58 UTC

    Study results updated

  3. Version 1

    9 Oct 2026, 12:41 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.